|
Feb 29
|
Kineta Announces Restructuring and Exploration of Strategic Alternatives
|
|
Jan 17
|
Kineta Provides Update on its Ongoing Phase 1/2 VISTA-101 Clinical Trial of KVA12123 in Patients with Advanced Solid Tumors
|
|
Nov 28
|
Kineta to Host KOL Event to Review New Data from VISTA-101 Clinical Trial of KVA12123 in Patients with Advanced Solid Tumors on December 5, 2023
|
|
Sep 28
|
Kineta Announces Participation at October Investor Conferences
|
|
Sep 25
|
Kineta to Present New Preclinical Data on Lead Anti-CD27 Agonist Antibody at AACR Special Conference on Tumor Immunology and Immunotherapy
|